Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 5.064% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1nc(SCc2ccc(Cl)c(Cl)c2)ncc1C(=O)O
b: COc1ccc(CCNc2nc(-c3cccc(NC(C)=O)c3)cs2)cc1OC
c: CCOCCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccco1
Answer: a. Cc1nc(SCc2ccc(Cl)c(Cl)c2)ncc1C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCc2ccc(Cl)c(Cl)c2)ncc1C(=O)O
Cc1nc(SCc2ccc(Cl)c(Cl)c2)ncc1C(=O)O
2-[(3,4-dichlorophenyl)methylsulfanyl]-4-methylpyrimidine-5-carboxylic acid